Targeting Activation-induced Cytidine Deaminase Overcomes Tumor Evasion of Immunotherapy by CTLs

Overview

Journal J Immunol

Specialty Allergy & Immunology

Date 2010 Apr 21

PMID 20404277

Citations 7

Authors

Jin-Qing Liu

Pramod S Joshi

Chuansong Wang

Hani Y El-Omrani

Yi Xiao

Xiuping Liu

John P Hagan

Chang-Gong Liu

Lai-Chu Wu

Xue-Feng Bai

Affiliations

Soon will be listed here.

Abstract

Activation-induced cytidine deaminase (AID) is an enzyme essential for the generation of Ab diversity in B cells and is considered to be a general gene mutator. In addition, AID expression was also implicated in the pathogenesis of human B cell malignancies and associated with poor prognosis. In this study, we report that small interfering RNA silencing of AID in plasmacytoma dramatically increased its susceptibility to immunotherapy by CTLs. AID silencing did not decrease the mutation frequencies of tumor Ag gene P1A. Gene-array analysis showed dramatically altered expression of a number of genes in AID-silenced plasmacytoma cells, and upregulation of CD200 was shown to be in favor of tumor eradication by CTLs. Taken together, we demonstrate a novel function of AID in tumor evasion of CTL therapy and that targeting AID should be beneficial in the immunotherapy of AID-positive tumors.

Citing Articles

Small Molecule Inhibitors of Activation-Induced Deaminase Decrease Class Switch Recombination in B Cells.

Alvarez-Gonzalez J, Yasgar A, Maul R, Rieffer A, Crawford D, Salamango D ACS Pharmacol Transl Sci. 2021; 4(3):1214-1226.

PMID: 34151211 PMC: 8205235. DOI: 10.1021/acsptsci.1c00064.

Epstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth.

Liu Z, Liu J, Shi Y, Zhu X, Liu Z, Li M Oncoimmunology. 2015; 4(7):e989137.

PMID: 26140252 PMC: 4485763. DOI: 10.4161/2162402X.2014.989137.

Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy.

Kawamura K, Wada A, Wang J, Li Q, Ishii A, Tsujimura H J Cancer Res Clin Oncol. 2015; 142(1):27-36.

PMID: 26077666 DOI: 10.1007/s00432-015-2001-7.

Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis.

Wang Z, Liu J, Liu Z, Shen R, Zhang G, Xu J J Immunol. 2013; 190(5):2415-23.

PMID: 23345334 PMC: 3578001. DOI: 10.4049/jimmunol.1202535.

IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.

Liu Z, Liu J, Talebian F, Wu L, Li S, Bai X Eur J Immunol. 2012; 43(2):468-79.

PMID: 23225163 PMC: 3625660. DOI: 10.1002/eji.201242930.

References

Bai X, Liu J, Li O, Zheng P, Liu Y . Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes. J Clin Invest. 2003; 111(10):1487-96. PMC: 155049. DOI: 10.1172/JCI17656. View

Babbage G, Garand R, Robillard N, Zojer N, Stevenson F, Sahota S . Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events. Blood. 2003; 103(7):2795-8. DOI: 10.1182/blood-2003-05-1632. View

Hoek R, Ruuls S, Murphy C, Wright G, Goddard R, Zurawski S . Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science. 2000; 290(5497):1768-71. DOI: 10.1126/science.290.5497.1768. View

Bhutani N, Brady J, Damian M, Sacco A, Corbel S, Blau H . Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature. 2009; 463(7284):1042-7. PMC: 2906123. DOI: 10.1038/nature08752. View

Kaspar P, Dvorakova M, Kralova J, Pajer P, Kozmik Z, Dvorak M . Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein. J Biol Chem. 1999; 274(20):14422-8. DOI: 10.1074/jbc.274.20.14422. View

Yee C, Thompson J, Byrd D, Riddell S, Roche P, Celis E . Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci U S A. 2002; 99(25):16168-73. PMC: 138583. DOI: 10.1073/pnas.242600099. View

Honjo T, Muramatsu M, Fagarasan S . AID: how does it aid antibody diversity?. Immunity. 2004; 20(6):659-68. DOI: 10.1016/j.immuni.2004.05.011. View

Feldhahn N, Henke N, Melchior K, Duy C, Soh B, Klein F . Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells. J Exp Med. 2007; 204(5):1157-66. PMC: 2118573. DOI: 10.1084/jem.20062662. View

Zhang B, Karrison T, Rowley D, Schreiber H . IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers. J Clin Invest. 2008; 118(4):1398-404. PMC: 2262029. DOI: 10.1172/JCI33522. View

10.

Rai K, Huggins I, James S, Karpf A, Jones D, Cairns B . DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell. 2008; 135(7):1201-12. PMC: 2629358. DOI: 10.1016/j.cell.2008.11.042. View

11.

Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura Y, Hamano S . Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest. 2005; 115(11):2979-91. PMC: 1257532. DOI: 10.1172/JCI23298. View

12.

Spiotto M, Rowley D, Schreiber H . Bystander elimination of antigen loss variants in established tumors. Nat Med. 2004; 10(3):294-8. DOI: 10.1038/nm999. View

13.

Zhang B, Bowerman N, Salama J, Schmidt H, Spiotto M, Schietinger A . Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J Exp Med. 2007; 204(1):49-55. PMC: 2118433. DOI: 10.1084/jem.20062056. View

14.

Wright G, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec M, Bigler M . Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol. 2003; 171(6):3034-46. DOI: 10.4049/jimmunol.171.6.3034. View

15.

Albesiano E, Messmer B, Damle R, Allen S, Rai K, Chiorazzi N . Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood. 2003; 102(9):3333-9. DOI: 10.1182/blood-2003-05-1585. View

16.

Ramiro A, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M . AID is required for c-myc/IgH chromosome translocations in vivo. Cell. 2004; 118(4):431-8. DOI: 10.1016/j.cell.2004.08.006. View

17.

Ido A, Miura Y, Tamaoki T . Activation of ATBF1, a multiple-homeodomain zinc-finger gene, during neuronal differentiation of murine embryonal carcinoma cells. Dev Biol. 1994; 163(1):184-7. DOI: 10.1006/dbio.1994.1134. View

18.

Smit L, Bende R, Aten J, Guikema J, Aarts W, van Noesel C . Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res. 2003; 63(14):3894-8. View

19.

Popp C, Dean W, Feng S, Cokus S, Andrews S, Pellegrini M . Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature. 2010; 463(7284):1101-5. PMC: 2965733. DOI: 10.1038/nature08829. View

20.

Yoshikawa K, Okazaki I, Eto T, Kinoshita K, Muramatsu M, Nagaoka H . AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science. 2002; 296(5575):2033-6. DOI: 10.1126/science.1071556. View